ATE554790T1 - Verfahren und zusammensetzungen zur diagnose von asthma - Google Patents

Verfahren und zusammensetzungen zur diagnose von asthma

Info

Publication number
ATE554790T1
ATE554790T1 AT02795780T AT02795780T ATE554790T1 AT E554790 T1 ATE554790 T1 AT E554790T1 AT 02795780 T AT02795780 T AT 02795780T AT 02795780 T AT02795780 T AT 02795780T AT E554790 T1 ATE554790 T1 AT E554790T1
Authority
AT
Austria
Prior art keywords
compositions
methods
diagnosing asthma
asthma
diagnosing
Prior art date
Application number
AT02795780T
Other languages
English (en)
Inventor
Kenneth Broughton
John Gordon Driskill
Original Assignee
Univ Wyoming
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Wyoming filed Critical Univ Wyoming
Application granted granted Critical
Publication of ATE554790T1 publication Critical patent/ATE554790T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/53—Colony-stimulating factor [CSF]
    • G01N2333/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5425—IL-9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5446—IL-16
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/12—Pulmonary diseases
    • G01N2800/122—Chronic or obstructive airway disorders, e.g. asthma COPD

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT02795780T 2001-12-07 2002-12-09 Verfahren und zusammensetzungen zur diagnose von asthma ATE554790T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33838901P 2001-12-07 2001-12-07
PCT/US2002/039198 WO2003049599A2 (en) 2001-12-07 2002-12-09 Methods and compositions for the diagnosis of asthma

Publications (1)

Publication Number Publication Date
ATE554790T1 true ATE554790T1 (de) 2012-05-15

Family

ID=23324626

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02795780T ATE554790T1 (de) 2001-12-07 2002-12-09 Verfahren und zusammensetzungen zur diagnose von asthma

Country Status (7)

Country Link
US (1) US20050036943A1 (de)
EP (1) EP1450859B1 (de)
JP (1) JP4489431B2 (de)
AT (1) ATE554790T1 (de)
AU (1) AU2002360519B2 (de)
CA (1) CA2469459C (de)
WO (1) WO2003049599A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6207157B2 (ja) * 2010-09-24 2017-10-04 株式会社 バイオエルティ Ｔｈ３マーチ関連疾患の治療及び予防用医薬組成物
US20150198589A1 (en) * 2012-06-15 2015-07-16 Ekrem Erbiz Use of edta tube with gel in elisa method
JP7033774B2 (ja) * 2017-08-25 2022-03-11 国立大学法人 東京大学 抗サイトカイン抗体療法
US11925485B2 (en) 2017-12-06 2024-03-12 Cardiac Pacemakers, Inc. Non-invasive system for monitoring and treating respiratory distress
US11690559B2 (en) * 2017-12-06 2023-07-04 Cardiac Pacemakers, Inc. Method and apparatus for monitoring respiratory distress based on autonomic imbalance

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US5843440A (en) * 1990-10-03 1998-12-01 Redcell Canada, Inc. Cellular and serum protein anchors for modulating pharmacokinetics
US6156503A (en) * 1997-03-03 2000-12-05 The Regents Of The University Of California Diagnosing asthma patients predisposed to adverse β-agonist reactions
US6306897B1 (en) * 1999-03-19 2001-10-23 Parker Hughes Institute Calanolides for inhibiting BTK
US6846486B1 (en) * 2000-02-24 2005-01-25 Advanced Biotherapy Concepts, Inc. Method of treating allergy by administering an anti-histamine antibody
US6630176B2 (en) * 2000-03-07 2003-10-07 Mount Sinai School Of Medicine Of New York University Herbal remedies for treating allergies and asthma
US7384736B2 (en) * 2001-09-06 2008-06-10 Decode Genetics Ehf. Methods for predicting drug sensitivity in patients afflicted with an inflammatory disease

Also Published As

Publication number Publication date
JP2005512068A (ja) 2005-04-28
WO2003049599A8 (en) 2004-10-21
WO2003049599A2 (en) 2003-06-19
AU2002360519B2 (en) 2008-09-25
WO2003049599A3 (en) 2003-12-18
EP1450859A2 (de) 2004-09-01
CA2469459C (en) 2011-10-18
US20050036943A1 (en) 2005-02-17
EP1450859A4 (de) 2005-11-02
EP1450859B1 (de) 2012-04-25
JP4489431B2 (ja) 2010-06-23
CA2469459A1 (en) 2003-06-19
AU2002360519A1 (en) 2003-06-23

Similar Documents

Publication Publication Date Title
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE60329165D1 (de) Detektion und/oder beobachtung von synuclein-assoziierten krankheiten
DE60205433D1 (de) Vorrichtung und Verfahren zur Auswertung der medizinischen Einrichtungen
DE69942614D1 (de) Vorrichtung zur diagnose und therapie von elektrophysiologischen krankheiten
DE60109311D1 (de) Kit zur simultanen diagnose mehrerer ansteckender krankheiten und verfahren zu seiner herstellung
ATE451477T1 (de) Diagnose und überwachung von hepatozellulärem karzinom
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DE60333195D1 (de) Verfahren zur diagnose des myokardinfarktrisikos
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE60134158D1 (de) Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs
BR0007702A (pt) Método e kit de diagnóstico para diagnose de endometriose
ATE320272T1 (de) Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm- lumenbildgebung
DE602005023973D1 (de) Verfahren zur diagnose von chronischem stress und verwandten erkrankungen
ATE534397T1 (de) Verwendung von dmbt1 zum einfangen von sulfat- und phosphatgruppen exponierenden agenzien
ES2179867T3 (es) Entrecruzamientos de piridinolina como marcadores de actividad de enfermedad periodontal o peri-implante.
ATE240352T1 (de) Komplexverbindungen zur diagnose von gefässerkrankungen
ATE546544T1 (de) Verfahren zur diagnose und behandlung von lungenkrebs
ATE397090T1 (de) Verfahren und verbindungen zur diagnose von entzündlichen erkrankungen und identifizierung von pharmakologischen mitteln zur behandlung von entzündlichen erkrankungen
ATE441859T1 (de) Verfahren zur diagnose der immunität wiederkehrenden spontanen schwangerschaftsabbruchs sowie verfahren zur behandlung und überwachung
ATE473295T1 (de) Nukleotidträger zur diagnose und therapie oraler erkrankungen
RU2003122545A (ru) Способ диагностики заболеваний органов дыхания
ATE489634T1 (de) In vitro methode zur klinischen diagnose.